Organon & Co
740 hedge funds and large institutions have $3.07B invested in Organon & Co in 2024 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 209 increasing their positions, 243 reducing their positions, and 102 closing their positions.
27% more first-time investments, than exits
New positions opened: 130 | Existing positions closed: 102
18% more call options, than puts
Call options by funds: $25.5M | Put options by funds: $21.7M
2.48% more ownership
Funds ownership: 77.38% → 79.87% (+2.5%)
2% more funds holding
Funds holding: 724 → 740 (+16)
14% less repeat investments, than reductions
Existing positions increased: 209 | Existing positions reduced: 243
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less capital invested
Capital invested by funds: $3.81B → $3.07B (-$737M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$182M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$46.9M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$24M |
| 4 |
BlackRock
New York
|
+$10.6M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Slate Path Capital
New York
|
-$47.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$47M |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$33.5M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$33M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$28.3M |
OGN Hedge Fund Activity: Q4 2024 in Review
740 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q4 2024, worth a combined $3.07B — down 19% from $3.81B a quarter earlier.
Buyers outnumbered sellers: 130 funds opened new OGN positions and 102 closed out — a net gain of 28 holders — while 209 added to existing stakes and 243 trimmed.
The largest buyer was Pacer Advisors, adding an estimated $182M. The largest seller was Slate Path Capital, exiting entirely with an estimated $47.1M sold.
- 740 institutional investors held Organon & Co (OGN) as of Q4 2024, up from 724 in Q3 2024.
- Funds reported $3.07B of Organon & Co stock for Q4 2024, down 19% quarter-over-quarter.
- 130 funds opened new Organon & Co positions in Q4 2024 and 102 closed out, a net change of +28 holders.
- The largest Organon & Co buyer in Q4 2024 was Pacer Advisors, an estimated $182M added.
- The largest Organon & Co seller in Q4 2024 was Slate Path Capital, an estimated $47.1M sold.
Based on aggregated 13F filings for Q4 2024.